Johnson & Johnson (JNJ) is acquiring Abiomed (ABMD) in a deal expected to close soon pending final conditions.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on STLD:
- Steel Dynamics Provides Fourth Quarter 2022 Earnings Guidance
- Steel Dynamics sees Q4 adjusted EPS $4.10-$4.14, consensus $3.84
- Steel Dynamics downgraded to Neutral from Buy at UBS
- U.S, EU weigh tariffs on Chinese steel, aluminum, Bloomberg says
- Steel Dynamics Announces Additional $1.5 Billion Share Repurchase Authorization and Fourth Quarter 2022 Cash Dividend